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ABSTRACT
Introduction Identifying acute hypercapnic respiratory
failure is crucial in the initial management of acute
exacerbations of COPD. Guidelines recommend obtaining
arterial blood samples but these are more difﬁcult to
obtain than venous. We assessed whether blood gas
values derived from venous blood could replace arterial
at initial assessment.
Methods Patients requiring hospital treatment for an
exacerbation of COPD had paired arterial and venous
samples taken. Bland–Altman analyses were performed
to assess agreement between arterial and venous pH,
CO2 and HCO

3 . The relationship between SpO2 and
SaO2 was assessed. The number of attempts and pain
scores for each sample were measured.
Results 234 patients were studied. There was good
agreement between arterial and venous measures of pH
and HCO3 (mean difference 0.03 and −0.04, limits of
agreement −0.05 to 0.11 and −2.90 to 2.82,
respectively), and between SaO2 and SpO2 (in patients
with an SpO2 of >80%). Arterial sampling required more
attempts and was more painful than venous (mean pain
score 4 (IQR 2–5) and 1 (IQR 0–2), respectively,
p<0.001).
Conclusions Arterial sampling is more difﬁcult and
more painful than venous sampling. There is good
agreement between pH and HCO3 values derived from
venous and arterial blood, and between pulse oximetry
and arterial blood gas oxygen saturations. These
agreements could allow the initial assessment of COPD
exacerbations to be based on venous blood gas analysis
and pulse oximetry, simplifying the care pathway and
improving the patient experience.
INTRODUCTION
Exacerbations of COPD are the second most
common cause of emergency hospital admission in
the UK, with an estimated 94 000 per year.1 COPD
exacerbations have a very high risk of mortality;
50% of people with a severe exacerbation will die
within 4 years of an admission.1
The recognition that high ﬂow oxygen therapy
can induce hypercapnia in susceptible patients
during exacerbations of COPD,2 and that respira-
tory acidosis is associated with a worse outcome3 4
led to a rise in arterial blood gas (ABG) sampling
to measure pH, PaCO2, PaO2 and HCO

3 . The
current National Institute for Health and Care
Excellence (NICE) COPD guidelines recommend
obtaining an ABG in all patients admitted to hos-
pital with a COPD exacerbation.5 Arterial sampling
is more technically difﬁcult and reportedly more
painful6 than venous blood gas (VBG) sampling.
Administration of local anaesthetic prior to arterial
sampling is recommended but seldom used, as
shown in a recent survey of junior doctors where
91% never or rarely used local anaesthesia when
performing arterial puncture.7 Using less invasive
measures of pCO2 and SaO2 could greatly beneﬁt
patients by both decreasing pain and streamlining
the care pathway.
Recent meta-analysis data suggest good agree-
ment between venous and arterial measurements of
pH, HCO3 and base excess.
8–11 In diabetes care
arterial sampling has been replaced with venous for
the monitoring of diabetic ketoacidosis.12 The use
of venous samples to guide treatment in COPD
exacerbations has been limited, perhaps because the
relationship between arterial and venous measures
of CO2 is less strong, although a PvCO2 of >6 kPa
has been shown to have 100% (95% CI 97% to
100%) sensitivity in identifying patients with clinic-
ally relevant hypercapnia.13
We set out to assess the relationship between
arterial and venous measures of PCO2, pH and
HCO3 , and between arterial and pulse oximetry
oxygen saturations during exacerbations of COPD,
in order to establish whether VBG analysis
combined with pulse oximetry could replace ABG
analysis in the initial assessment of COPD
exacerbations.
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Key messages
What is the key question?
▸ Can venous blood gas analysis replace arterial
blood gas sampling in the initial assessment of
patients with COPD exacerbations?
What is the bottom line?
▸ Over two-thirds of arterial blood gas samples
could be replaced by the simpler and safer use
of venous blood gas analysis.
Why read on?
▸ This paper describes agreement between
arteriovenous measures for key blood gas
parameters and presents a simple algorithm for
the substitution of arterial blood gas sampling
with venous in the initial management of
patients admitted to hospital with a COPD
exacerbation.
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METHODS
Patients admitted to Nottingham University Hospitals Trust with
a doctor-diagnosed exacerbation of COPD were considered for
inclusion. Patients were included in the study unless they
refused. If they were unable to give informed consent an
approved alternative decision maker was approached. Recruited
patients had an ABG and pulse oximetry performed by a junior
doctor as per routine care, and a parallel paired VBG sample.
Care was guided by the ABG results as per current clinical
guidelines.
Arterial samples were collected via a heparinised needle and
syringe system, and venous samples were aspirated into a separ-
ate heparinised blood gas syringe via a butterﬂy needle or
needle. Samples were processed as soon as possible on the same
ward-based blood gas analyser. Analysers were calibrated regu-
larly in accordance with the department of medical physics
standard operating procedure. Research nurses collected data on
demographics, body mass index, smoking status, pain scores
(visual analogue scores 0=no pain, 10=worst pain imaginable)
for arterial and venous sampling and the number of attempts
taken to acquire each sample.
The main outcomes were the agreements between ABG and
VBG parameters, and between ABG and pulse oximetry mea-
sures of oxygen saturation. Secondary outcome measures
included pain scores, and the number of attempts taken to
obtain blood.
Statistical analysis
Agreements between venous and arterial samples for CO2, pH
and HCO3 , and between SaO2 and SpO2 were assessed using
the Bland–Altman method. Previous studies found 40% of
patients attending the Emergency Department with an exacerba-
tion of COPD had arterial hypercarbia, and it was estimated
that 200 patients would allow us to calculate the sensitivity of
the venous CO2 screening threshold for detection of arterial
hypercarbia with CIs of <5%.9 13 Using this sample size of 200,
our 95% CI around the limits of agreement are estimated at
0.24× the SD of the mean difference for which pH is
±0.001.14
Missing data were not imputed. Receiver operating character-
istic curves were used to estimate how venous CO2, pH, HCO

3
predicted arterial values and how SpO2 predicted SaO2. Area
under the curve, sensitivity and speciﬁcity were calculated to
predict an arterial pH ≥7.35 and bicarbonate ≥21, and for the
pulse oximetry result to predict an SaO2 of ≥92%.
RESULTS
Over the time course of the study (from 3 February 2013 to 10
January 2014), there were 1376 admissions with a coded diag-
nosis of COPD exacerbation. Of these, 234 participants were
recruited and had at least one paired sample of blood gases.
Twelve patients declined study participation. The mean age of
the population was 71 years (SD 10.8) and 50% of the popula-
tion was male. Characteristics of the population are shown in
table 1.
There was good agreement between arterial and venous pH,
and between arterial and venous HCO3 (ﬁgures 1 and 2 and
Table 1 Characteristics of study population
n N
Age (years) mean (SD) 71.0 (10.8) 234
Sex N (%)
Male 118 (50.4)
Female 116 (49.6)
BMI (kg/m2) mean (SD) 26.2 (7.9) 223
Smoking status N (%) 230
Never 14 (6.1)
Ex 146 (63.5)
Current 70 (30.4)
Clinical measures mean (SD)
Heart rate (bpm) 98.7 (20.8) 234
Respiratory rate 23.6 (5.9) 234
Systolic blood pressure (mm Hg) 130.7 (23.7) 234
Diastolic blood pressure (mm Hg) 71.3 (13.1) 234
BMI, body mass index.
Figure 1 Bland–Altman plot for
arterial and venous blood pH levels.
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Figure 2 Bland–Altman plot for
arterial and venous blood bicarbonate
levels.
Table 2 Agreement between arterial and venous pCO2, pH and HCO3
−
ABG (mean) (SD) VBG (mean) (SD) Mean difference (ABG–VBG) (95% CI) 95% limits of agreement N
pH 7.40 (0.09) 7.37 (0.08) 0.03 (0.02 to 0.04) −0.05 to 0.11 234
HCO3 (mEq/L) 29.7 (6.3) 29.7 (6.4) −0.04 (−0.22 to 0.15) −2.90 to 2.82 232
pCO2 (kPa) 6.89 (2.40) 7.63 (2.41) −0.75 (CI −0.89 to −0.61) −2.91 to 1.41 225
ABG, arterial blood gas; VBG, venous blood gas.
Table 3 Agreement between SaO2 and SpO2
SaO2 (mean) (SD) SpO2 (mean) (SD) Mean difference (SaO2–SpO2) (95% CI) 95% limits of agreement N
Oxygen percentage saturation* 91.2 (6.0) 91.0 (4.0) −0.17 (CI −0.89 to 0.56) −11.12 to 10.78 224
*In patients with SpO2 ≥80%.
Figure 3 Bland–Altman plot for
arterial and venous blood CO2 levels.
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tables 2 and 3), however, the CO2 values varied signiﬁcantly
(ﬁgure 3). There was also a good agreement between SaO2 and
SpO2 in those patients with an SpO2 of ≥80% (ﬁgure 4 and
tables 2 and 3). These relationships were not signiﬁcantly differ-
ent in the 20 patients with an admission systolic blood pressure
of <100 mm Hg (see online supplementary material).
Venous blood cut points for managing acute exacerbations
of COPD
Given the relationships observed, we calculated the sensitivity
and speciﬁcity of a VBG pH and HCO3 to correctly identify an
arterial pH of ≥7.35, and an arterial HCO3 of ≥21, as well as
an SpO2 to identify an SaO2 of ≥92% (table 4). A venous pH of
7.34, a venous HCO3 of 21.45 and an SpO2 of 91.5 would
have correctly classiﬁed 87% (95% CI 82% to 91%), 97%
(95% CI 93% to 98%) and 71% (95% CI 65% to 77%) of
patients, respectively. In terms of speciﬁcity, 96% of patients
with an ABG pH of ≥7.35 also had a VBG pH of ≥7.35 (tables
5 and 6).
We used current oxygen guidelines15 to calculate how many
ABG samples may have been avoided if the venous cut points
were used instead. Of our 234 patients, 72 (31%) had a venous
pH <7.35. Of the 162 with a venous pH ≥7.35, only two had
an arterial pH of <7.35.
Consequently, we estimate approximately two-thirds of ABGs
can safely be avoided in the initial assessment of COPD exacer-
bations. This ﬁgure does not factor in the repeat attempts
needed to obtain arterial blood. Using these data, we suggest a
new algorithm for the management of COPD exacerbations
based on the current guidelines (ﬁgure 5).
Timing of samples
We assessed the mean difference in time between the paired
arterial and venous samples to see if a delay between samples
had an effect on the relationship between ABG and VBG
parameters. The mean time difference was −4.18 min, SD
16.92, range −58.98 to 78.64 min (arterial–venous). Given the
range, we repeated our analysis using the 168 paired
samples that were performed within 15 min of each other.
This did not affect the relationships (see online supplementary
table).
Pain score
The median pain score was signiﬁcantly higher for ABG sam-
pling as compared with VBG (p<0.001). In addition, there was
Figure 4 Bland–Altman plot for
SaO2 and SpO2 levels. (This graph only
includes patients with a pulse oximetry
value of >80%.)
Table 4 Pain score and number of venesection attempts
n N
Pain score (median and IQR)
Arterial pain score 4 (2–5) 187
Venous pain score 1 (0–2) 205
Number of attempts (N and %)
Arterial number of attempts
1 162 (69.2)
2 55 (23.5)
3 10 (4.3)
≥4 7 (3.0) 234
Venous number of attempts
1 211 (90.2)
2 18 (7.7)
≥3 5 (2.1) 234
Table 5 Predictive performance of venous blood gas parameters
Venous
blood
cut-off AUC
Sensitivity
%
Specificity
%
Correctly
classified
%* N
Arterial pH
≥7.35
7.34 0.92 88.9 95.6 87 234
HCO3
(mEq/L) ≥21
21.45 0.98 96 100 97 232
*Correctly classified refers to percentage of patients correctly classified both above
and below given parameter. AUC; area under curve.
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a signiﬁcantly greater number of attempts taken to obtain an
ABG sample (69.2% achieved at ﬁrst attempt) compared with
VBG, where 90.2% were obtained at the ﬁrst attempt
(p<0.001) (table 4).
DISCUSSION
Exacerbations of COPD are a major cause of morbidity and
mortality worldwide,16 and our local ﬁgures reﬂect this. In
2010, there were 1343 admissions into Nottingham University
Hospitals Trust. The management of COPD exacerbations
depends upon quickly identifying acute hypercapnic respiratory
failure. In this study, we set out to establish if ABG analysis
obtained for the initial assessment of COPD exacerbations
could be replaced by VBG analysis and pulse oximetry when
assessing for acute hypercapnic respiratory failure.
We examined the agreement between ABG and VBG para-
meters and between ABG and pulse oximetry measurements of
oxygen saturation in COPD exacerbations and found acceptable
agreement for pH, HCO3 and for SaO2 at an SpO2 >80%. We
found that 96% of patients with an ABG pH of <7.35 also had
a VBG pH of <7.35 and that only two patients were misclassi-
ﬁed as having a normal venous pH but a low arterial pH.
A meta-analysis of ﬁve studies examining the utility of periph-
eral VBG analyses in exacerbations of COPD in the emergency
department found that there was agreement between arterial
and venous pH and HCO3 .
9 The weighted average difference
for pCO2 was 0.79 kPa (n=440), whereas those for pH and
HCO3 were 0.028 and 1.34 mmol (n=239), respectively. The
relatively weaker relationship seen between SpO2 and SaO2 at
lower levels is unsurprising as commercial pulse oximeters are
more accurate at higher oxygen saturations and signiﬁcantly less
accurate below 80%.17 18 The proposed algorithm reﬂects this;
any patient with an SpO2 of <80% needs an immediate ABG.
Our study has limitations. There was a small time gap
between sample acquisition and processing, although results did
not change signiﬁcantly when this was factored in. We also had
Table 6 Predictive performance of pulse oximetry
SpO2
cut-off AUC
Sensitivity
%
Specificity
%
Correctly
classified* N
SaO2 91.5% 0.75 78 72 71 233
*Correctly classified refers to percentage of patients correctly classified both above
and below given parameter.
Figure 5 Suggested algorithm for blood gas analysis during COPD exacerbation (adapted from Kelly10). ABG, arterial blood gas; ICU, intensive
care unit; NIV, non-invasive ventilation.
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a pragmatic approach to sample collection which depended
upon our junior doctors and specialist nurses; consequently, it
was difﬁcult to fully exclude mixed arterial/venous stabs which
may explain why the sensitivities and speciﬁcities to predict an
arterial pH of <7.35 were not 100%. We stress in our algorithm
that if there is a risk or actual clinical deterioration an arterial
analysis should be performed.
Arterial sampling was more painful than venous and required
more attempts. While the pain of arterial sampling can be
reduced by using local anaesthetic, it is not widely used.7
Although capillary sampling is used in speciality wards, wide-
spread adoption is difﬁcult because of the extra training,
resources and time needed. As patients with exacerbations of
COPD almost always have venipuncture to obtain samples for
full blood count and blood chemistry analysis, VBG analysis can
be performed on the same sample.
Our results suggest that the close relationship between venous
and arterial acid base parameters, and between oxygen satura-
tions obtained from pulse oximetry and arterial blood, could
allow the initial assessment of acute COPD exacerbations to be
based on a combined measurement of a VBG pH and SpO2.
This would mean a change in practice as the current oxygen
guidelines published by the British Thoracic Society15 state that
any patient requiring supplemental oxygen to achieve a target
SpO2 of 92%–94% should have an arterial blood or arteriolised
capillary blood gas performed.
We suggest that arterial sampling is reserved for patients with
a venous pH of <7.35. The approach of using venous blood
ﬁrst has obvious beneﬁts. Only one blood draw would be
required resulting in less pain and a lower risk of bruising and
associated side effects. Less training would be required to ini-
tially assess acid/base status, and fewer attempts to draw blood
would be needed, needing less equipment and simplifying the
care pathway for COPD exacerbations. We conservatively esti-
mate that >66% of ABG attempts would be avoided and
replaced by VBG sampling.
CONCLUSION
There is a good agreement between pH and HCO3 values
derived from venous and arterial blood, and between pulse
oximetry and ABG oxygen saturations. These agreements could
allow the initial assessment of COPD exacerbations to be based
on VBG analysis and pulse oximetry rather than ABG analysis,
simplifying the care pathway.
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